Promisia Healthcare Limited · NZX:PHL
Promisia Healthcare — FY2026 Earnings Presentation
14 slides from Promisia Healthcare's earnings presentation, Mar 31, 2026
Slide 1: FY26 Full Year Results
FY26 Full Year Results For the year ended 31 March 2026 Investor Presentation 1
Slide 2: FY26: focused execution, delivering outperformance
FY26: focused execution, delivering outperformance Material improvement across all key financial and operational metrics, a result of progressing our clear strategic priorities. $40.1m $6.6m $6.4m Operating revenue Underlying EBITDAF Net operating cash flows +29% vs FY25 +58% vs FY25 +87% vs FY25 94
Slide 3: Key operational highlights
Key operational highlights We set clear operational priorities at the start of the year and delivered against them, lifting performance across the portfolio through stronger execution, clinical standards and operational discipline. Nelson Street repositioned to meet demand Cromwell embedded into the
Slide 4: Revenue and cost control delivering earnings growth
Revenue and cost control delivering earnings growth ▲ Operating revenue increased 29% to $40.1m Driven by higher occupancy, a full year of Cromwell trading, Underlying EBITDAF1 and growth in deferred management fees. +76% over 2 years ▲ Operating expenses managed effectively Operating expenses were
Slide 5: Building a track record of value creation
Building a track record of value creation A stronger operating platform and asset base now provide a clear foundation for continued growth. ▲ NTA per share increased 38% to $1.09 Up from $0.79 at March 2025, and more than double the $0.46 NTA per share recorded at March 2023. +137% over 3 years ▲ Po
Slide 6: Simplified debt profile
Simplified debt profile Bank debt • Single bank lender (BNZ) with one consolidated facility, cross- Group LVR on secured bank debt securitised across the group • $31.1m total facility, with $3.3m undrawn for operating liquidity • Weighted average interest rate on drawn debt c.5.7%, down significantl
Slide 7: Allocating capital to grow long-term shareholder value
Allocating capital to grow long-term shareholder value Our capital management framework prioritises four core areas, with shareholder returns now supported through the new dividend policy. Advancing ownership of Golden View Village Targeted value-add capex $2.16m p.a. of interest-free loan repayment
Slide 8: A disciplined, cash-based dividend policy
A disciplined, cash-based dividend policy Promisia has adopted a cash-based dividend policy from Underlying EBITDAF1 FY27. The policy is designed to return a portion of operating free Cash interest & cash flow to shareholders over time, while maintaining required required debt debt repayments repaym
Slide 9: FY27 Outlook
FY27 Outlook Continued earnings and cash flow growth • Underlying EBITDAF expected to increase to at least $8.0m (+20% YoY growth) • Group care occupancy expected to lift to at least 95% • Operating free cash flow expected to materially improve from FY26, supporting the ability to pay a dividend und
Slide 10: Appendix: Promisia at a glance
Appendix: Promisia at a glance Promisia Healthcare is a New Zealand-based provider of residential aged care and retirement village living, dedicated to delivering high-quality care and support Five 650+ 450+ Communities Residents Incredible staff Feilding Ranfurly Manor Nelson Street Care suites / F
Slide 11: Appendix: Our strategic vision for a stronger Promisia
Appendix: Our strategic vision for a stronger Promisia Connected communities Our where people feel cared for, included and valued Aspiration Vision A trusted and sustainable provider of quality people-care in the communities we serve People Delivery Occupancy Diversification Growth Expert governance
Slide 12: Appendix: Underlying EBITDAF and OFCF Calculation
Appendix: Underlying EBITDAF and OFCF Calculation Year ended 31 March ($000) 2026 2025 Profit before income tax 13,940 6,681 Plus: Depreciation expense 519 409 Plus: Impairment losses 37 491 Plus: Finance costs 3,565 2,904 Plus: EBITDA from discontinued operations - 927 EBITDA 18,061 11,412 Less: Fa
Slide 13: Disclaimer
Disclaimer This presentation has been prepared by Promisia Healthcare Limited (“PHL”). The information in this presentation is of a general nature only. It is not a complete description of PHL. This presentation is not a recommendation or offer of financial products for subscription, purchase or sal
Slide 14: Promisia
Promisia HEALTHCARE 2)